A bumper crop of revisions, including a stronger drug benefit, means the plan you enrolled in for 2024 may not be the best fit next year.
Related Posts
Some Calm Returns to Asian Markets Even as Trade Tensions Escalate
Stocks rise in China after Beijing announces support measures a day after market plunges triggered by tariffs imposed by President Trump.
The Anti-DEI Influencer Waging War on Lowe’s and Ford
From his home in Tennessee, the social media rabble-rouser Robby Starbuck is waging war on “woke” policies at places like Lowe’s and Ford. His timing […]
Farmers in Iowa Are Caught in Trump’s Trade War
With high costs and low prices for their crops, soybean and corn farmers were already nervous as they planned for planting season this year. A […]